NIH-funded research NIH-funded research

Conference on hemoglobin production and related diseases

Official title: Hemoglobin Switching Meeting

Funded at Boston Children's Hospital · NIH-11066017 · Data updated 2026-11-12

This conference is all about sharing the newest discoveries and treatments for blood disorders caused by problems with hemoglobin, bringing together scientists and doctors to collaborate and learn from each other, so they can better help people with these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startNovember 9, 2024
Project endOctober 31, 2025
Funding year2025
Award (this year)$10,000
NIH project number1R13HL177876-01
Project IDNIH-11066017 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit include individuals affected by hemoglobinopathies, such as beta-thalassemia, and those interested in the latest advancements in treatment.

Less likely to help

Patients not affected by hemoglobin disorders or those not engaged in research or clinical advancements in this area may not receive direct benefits from this conference.

What this research studies

This conference focuses on the latest discoveries in hemoglobin biosynthesis and treatments for hemoglobinopathies, which are common inherited blood disorders. It brings together basic scientists and clinicians to share insights and advancements in the field, fostering collaboration and innovation. Participants will have the opportunity to engage with early-stage researchers and established leaders, discussing both molecular and developmental aspects of these conditions. The conference aims to highlight new research findings and promote career development in this specialized area of hematology.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with hemoglobin disorders like beta-thalassemia.

How similar studies have gone: Previous conferences in this field have successfully advanced knowledge and treatment options, indicating a strong potential for impactful outcomes from this gathering.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Sankaran, Vijay Ganesh — Boston Children's Hospital
  • Study coordinator: Sankaran, Vijay Ganesh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.